Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ipilimumab × Tumor-Agnostic × Clear all

Phase

Status

Completed 13 Active not recruiting 5 Terminated 3 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 14 Thoracic 9 Gastrointestinal 8 Genitourinary 6 Head & Neck 4 Sarcoma 2 CNS 2 Breast 2 Tumor-Agnostic 1

Conditions

Neoplasms, Unknown Primary 1

Interventions

Radiotherapy 9 Cisplatin 8 Drug Therapy 7 Gemcitabine 6 Fluorouracil 6 Carboplatin 6 Blood Specimen Collection 6 Pemetrexed 5 Nivolumab 5 Capecitabine 5 Trastuzumab 4 Positron Emission Tomography Computed Tomography 4 Paclitaxel 4 Oxaliplatin 4 Docetaxel 4 Cetuximab 4 Biopsy 4 indibulin 3 icotinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiosurgery 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 Gallium-68 3 Everolimus 3 Data Collection 3 Aspirin 3 tislelizumab 2 spartalizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04131621 2020-04-15

CheCUP

University Hospital Heidelberg

Phase 2 Unknown

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡